| Cat. No. |
Product Name / Activity |
| 5550 |
E 2012 |
| γ-secretase modulator; Notch-sparing |
| 5208 |
E 64 |
| Potent and irreversible cysteine protease inhibitor |
| 4545 |
E 64d |
| Cathepsin inhibitor; interferes with autolysosomal digestion |
| 6785 |
E 7820 |
| α2 integrin inhibitor; anti-angiogenic |
| 1808 |
E-4031 dihydrochloride |
| KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr) |
| 3993 |
EB 1089 |
| Vitamin D receptor (VDR) agonist |
| 4140 |
EB 47 |
| Potent PARP-1 inhibitor |
| 1041 |
1-EBIO |
| Activator of epithelial KCa channels |
| 0518 |
EBPC |
| Aldose reductase inhibitor |
| 4701 |
EC 144 |
| High affinity, potent and selective Hsp90 inhibitor |
| 5849 |
EC 19 |
| Synthetic retinoid; induces differentiation of stem cells |
| 4011 |
EC 23 |
| Synthetic retinoid; induces differentiation of stem cells |
| 2811 |
EDTA |
| Chelating agent |
| 6986 |
EG 00229 trifluoroacetate |
| Neuropilin 1 (NRP1) receptor antagonist; inhibits VEGFA binding to NRP1 |
| 4524 |
EGCG |
| β-secretase inhibitor; inhibits amyloid assembly |
| 2807 |
EGTA |
| Calcium chelating agent |
| 1261 |
EHNA hydrochloride |
| Adenosine deaminase inhibitor |
| 3872 |
EHT 1864 |
| Potent Rac family inhibitor |
| 6248 |
EHop 016 |
| Rac inhibitor |
| 3378 |
EIPA |
| Inhibits TRPP3-mediated currents; also inhibits the Na+/H+ exchanger (NHE) |
| 6292 |
ELARR>GG |
| Negative control for ELA-32 (Cat.No.6291) |
| 6698 |
ELA-11 (human) |
| High affinity apelin agonist |
| 6293 |
ELA-14 (human) |
| Potent apelin agonist; bioactive fragment of ELA-32 (Cat. No. 6291) |
| 6294 |
ELA-14 negative control |
| Negative control for ELA-14 (Cat.No.6293) |
| 6697 |
ELA-21 (human) |
| High affinity apelin agonist |
| 6291 |
ELA-32 (human) |
| Potent and high affinity apelin agonist; stimulates angiogenesis |
| 4470 |
EMD 281014 hydrochloride |
| Selective 5-HT2A antagonist |
| 2382 |
EMD 386088 hydrochloride |
| Potent 5-HT6 agonist |
| 1849 |
EMD 66684 |
| Potent and selective non-peptide AT1 antagonist |
| 5646 |
EML 425 |
| Reversible and non-competitive CBP/p300 inhibitor |
| 4558 |
EMPA |
| Highly potent and selective OX2 antagonist; brain penetrant |
| 3576 |
(±)-5'-Chloro-5'-deoxy-ENBA |
| Highly selective A1 agonist |
| 2908 |
EO 1428 |
| Selective inhibitor of p38α and p38β2 |
| 4518 |
EPPTB |
| Trace amine 1 (TA1) receptor antagonist; also displays inverse agonism |
| 5567 |
EPZ 004777 |
| Highly potent DOT1L inhibitor |
| 6516 |
EPZ 015666 |
| Potent and selective PRMT5 inhibitor |
| 2471 |
ER 27319 maleate |
| Selective Syk kinase inhibitor |
| 3823 |
ER 50891 |
| Selective RARα antagonist |
| 5924 |
ER 819762 |
| Potent EP4 receptor antagonist; orally bioavailable |
| 4276 |
ERB 041 |
| Potent ERβ agonist |
| 6632 |
ERGi-USU |
| Rio2 kinase (RIOK2) inhibitor; inhibits ERG protein |
| 5393 |
ERK5-IN-1 |
| Potent and selective ERK5 inhibitor |
| 6320 |
ESI 05 |
| Epac2 inhibitor |
| 4773 |
ESI 09 |
| Epac inhibitor |
| 4702 |
ETP 45658 |
| Potent PI 3-kinase inhibitor; also inhibits DNA-PK and mTOR |
| 5183 |
ETP 45835 dihydrochloride |
| Mnk1 and Mnk2 inhibitor |
| 2780 |
EX 527 |
| Selective SIRT1 inhibitor |
| 5728 |
EXP 3174 |
| Potent and selective AT1 antagonist |
| 4876 |
Eact |
| Activator of Ca2+-activated Cl- channel transmembrane protein 16A (TMEM16A) |
| 5245 |
Ebselen |
| Glutathione peroxidase mimic; peroxynitrite scavenger |
| 6832 |
Ec2la |
| Positive allosteric modulator of CB2 receptors; active in vivo |
| 5520 |
Echinomycin |
| Highly potent and selective HIF-1α inhibitor |
| 3202 |
Echistatin, α1 isoform |
| αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor |
| 4784 |
Edaglitazone |
| Potent and selective PPARγ agonist; antidiabetic |
| 0786 |
Edaravone |
| Anti-ischemic and antioxidant |
| 3022 |
Edelfosine |
| Selective PI-PLC inhibitor, also PAF receptor agonist |
| 3922 |
Eeyarestatin I |
| Potent inhibitor of ER-associated protein degradation and translocation |
| 0792 |
Efaroxan hydrochloride |
| α2 antagonist and I1, I3 ligand |
| 3733 |
Efonidipine hydrochloride monoethanolate |
| CaV1.x and CaV3.x blocker |
| 5695 |
Eggmanone |
| Potent and selective PDE4 inhibitor; suppresses hedgehog signaling |
| 5979 |
Eicosapentaenoic Acid |
| Endogenous polyunsaturated fatty acid; stimulates ERK1/2 phosphorylation |
| 4646 |
Elacridar hydrochloride |
| P-gp inhibitor |
| 1914 |
Eledoisin |
| Potent tachykinin receptor ligand |
| 1920 |
Eledoisin-Related Peptide |
| Tachykinin receptor ligand |
| 3862 |
Eletriptan hydrobromide |
| 5-HT1B and 5-HT1D agonist; orally active |
| 5316 |
Elinogrel |
| P2Y12 antagonist |
| 2195 |
Eliprodil |
| Non-competitive and GluN2B-selective NMDA antagonist |
| 3058 |
Ellagic acid |
| Selective inhibitor of CK2. Also inhibits glutathione S-transferase |
| 3357 |
Ellipticine |
| Antitumor and intercalating agent; inhibits DNA topoisomerase II |
| 1860 |
Eltoprazine hydrochloride |
| 5-HT1 and 5-HT2C partial agonist |
| 2156 |
Embelin |
| Inhibitor of X-linked inhibitor of apoptosis (XIAP); cell-permeable and antitumor |
| 3811 |
Emodin |
| Naturally occurring anthraquinone; displays anti-inflammatory, antitumor and neuroprotective activity |
| 1055 |
Endomorphin-1 |
| Potent and selective μ agonist |
| 1056 |
Endomorphin-2 |
| Potent and selective μ agonist |
| 1160 |
Endothelin 1 (human, porcine) |
| Potent vasoconstrictor peptide |
| 1164 |
Endothelin 2 (human) |
| ETA/ETB agonist |
| 1162 |
Endothelin 3 (human, rat) |
| Potent vasoconstrictor |
| 1197 |
[Ala1,3,11,15]-Endothelin |
| Selective ETB agonist |
| 3705 |
Endoxifen |
| Potent antiestrogen; ERα ligand |
| 1889 |
[Leu5]-Enkephalin |
| Endogenous opioid agonist peptide |
| 1693 |
Enoximone |
| PDE3 inhibitor |
| 4720 |
Entacapone |
| Potent COMT inhibitor; blocks α-synuclein aggregation |
| 6234 |
Entecavir |
| Potent and selective hepatitis B virus inhibitor |
| 5994 |
Enzastaurin |
| Potent PKCβ inhibitor |
| 6102 |
Ep23, 5'-DY647 |
| High affinity fluorescently tagged aptamer for EpCam |
| 0684 |
(±)-Epibatidine |
| High affinity nAChR agonist |
| 6340 |
Epiblastin A |
| CK1 inhibitor; converts epiblast stem cells to ESCs and promotes ESC self-renewal |
| 3260 |
Epirubicin hydrochloride |
| Inhibits DNA synthesis and function. Inhibits DNA topoisomerase II |
| 2397 |
Eplerenone |
| Selective mineralocorticoid receptor antagonist |
| 4958 |
Eplivanserin hemifumarate |
| Potent and selective 5-HT2A antagonist |
| 2989 |
Epoprostenol |
| Endogenous IP receptor agonist |
| 3502 |
Epothilone B |
| Microtubule stabilization agent; promotes tubulin polymerization |
| 4725 |
Eptifibatide |
| Glycoprotein IIb/IIIa inhibitor; inhibits platelet aggregation |
| 6158 |
(S)-Equol |
| Potent estrogen receptor β (ERβ) agonist; dihydrotestosterone antagonist |
| 5449 |
Erastin |
| Mitochondrial VDAC modulator; also Ferroptosis activator |
| 4146 |
Ercalcidiol |
| Metabolite of vitamin D2 |
| 3970 |
Ercalcitriol |
| Active metabolite of vitamin D2 |
| 4796 |
Escitalopram oxalate |
| Selective serotonin reuptake inhibitor (SSRI) |
| 2823 |
α-Estradiol |
| Endogenous estrogen receptor agonist |
| 2824 |
β-Estradiol |
| Endogenous ER agonist |
| 3588 |
Estropipate |
| Estrogen receptor agonist and OATP1B1 inhibitor |
| 0438 |
Etazolate hydrochloride |
| PDE4 inhibitor |
| 6204 |
7-Ethoxyresorufin |
| Fluorometric CYP450 substrate |
| 1847 |
Eticlopride hydrochloride |
| D2 and D3 antagonist (D3 > D2) |
| 3113 |
Etifoxine hydrochloride |
| Ligand of the translocator protein (TSPO); also GABAA receptor potentiator |
| 3871 |
Etodolac |
| Selective cyclooxygenase-2 (COX-2) inhibitor; NSAID |
| 1471 |
Etomidate |
| GABA-mimetic; selectively interacts with β2- and β3-subunit containing GABAA receptors |
| 4539 |
(R)-(+)-Etomoxir sodium salt |
| Carnitine palmitoyltransferase I (CPT1) inhibitor |
| 1226 |
Etoposide |
| Topoisomerase II inhibitor |
| 0845 |
Evans Blue tetrasodium salt |
| Dye for assessing cell viability and blood brain barrier permeability; also EAAT inhibitor and iGluR antagonist |
| 6188 |
Everolimus |
| mTOR inhibitor; Immunosuppressant |
| 5833 |
Ex 26 |
| Potent and selective S1P1 receptor antagonist |
| 3759 |
Exemestane |
| Steroidal aromatase (CYP19) inhibitor |
| 2081 |
Exendin-3 (9-39) amide |
| Potent GLP-1 receptor antagonist |
| 1933 |
Exendin-4 |
| Potent GLP-1 receptor agonist |
| 1850 |
Exo1 |
| Inhibits Golgi-ER traffic; blocks exocytosis |